General Information of the Protein
Protein ID
PT00149
Protein Name
Nonstructural protein 5A
Gene Name
NS5A
Sequence
SGSWLRDVWDWICTVLTDFKTWLQSKLLPRIPGVPFLSCQRGYKGVWRGDGIMHTTCPCGAQITGHVKNGSMRIVGPKTCSNTWHGTFPINTYTTGPCTPSPAPNYSRALWRVAAEEYVEVTRVGDFHYVTGMTTDNVKCPCQVPAPEFFTEVDGVRLHRYAPACKPLLREEVTFMVGLNQYLVGSQLPCEPEPDVTVLTSMLTDPSHITAETAGRRLARGSPPSLASSSASQLSAPSLKATCTTRHDSPDADLIEANLLWRQEMGGNITRVESENKVVILDSFDPLQAEEDEREVSVPAEILRKSRKFPRAMPIWARPDYNPPLLESWKDPDYVPPVVHGCPLPPAKAPPIPPPRRKRTVVLTESTVSSALAELATKTFGSSGSSAVDSGTATAPPDQLPGDGDSGSDVESYSSMPPLEGEPGDPDLSDGSWSTMSEEASEDVVCC
    Show/Hide
Organism
Hepacivirus hominis
Protein Classification
Unclassified protein
Uniprot ID
Q5L478
Map of Molecular Bioactivity Related to the Protein
Map of Molecular Bioactivity Related to the Protein

Protein
Cell Line
Compound

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Protein
Cell Line ID: CL000322 , Huh-7-Lunet
Compound ID Compound Name Compound Formula
CP0032498
CVD-0019437
   Show/Hide
C40H50N8O6
 2
1
EC50 = 0.032 nM
   TI
   LI
   LO
   TS
2
EC50 = 0.079 nM
   TI
   LI
   LO
   TS
CP0868535
methyl N-[(3S,6S,9aR)-3-[5-[4-[4-[2-[(2S)-1-[(2S)-2-(methoxycarbonylamino)-3-methyl-butanoyl]pyrrolidin-2-yl]-1H-imidazol-5-yl]phenyl]phenyl]-1H-imidazol-2-yl]-5-oxo-1,2,3,6,7,8,9,9a-octahydropyrrolo[1,2-a]azepin-6-yl]carbamate
   Show/Hide
C40H48N8O6
 2
1
EC50 = 0.037 nM
   TI
   LI
   LO
   TS
2
EC50 = 0.471 nM
   TI
   LI
   LO
   TS
CP0960971
methyl N-[(3S,6S,9aS)-3-[5-[4-[4-[2-[(8S)-7-[(2S)-2-(methoxycarbonylamino)-3-methyl-butanoyl]-1,4-dioxa-7-azaspiro[4.4]nonan-8-yl]-1H-imidazol-5-yl]phenyl]phenyl]-1H-imidazol-2-yl]-5-oxo-1,2,3,6,7,8,9,9a-octahydropyrrolo[1,2-a]azepin-6-yl]carbamate
   Show/Hide
C42H50N8O8
 2
1
EC50 = 0.046 nM
   TI
   LI
   LO
   TS
2
EC50 = 8.581 nM
   TI
   LI
   LO
   TS
CP0951257
methyl N-[(3S,6R,9aR)-3-[5-[4-[4-[2-[(8S)-7-[(2S)-2-(methoxycarbonylamino)-3-methyl-butanoyl]-1,4-dioxa-7-azaspiro[4.4]nonan-8-yl]-1H-imidazol-5-yl]phenyl]phenyl]-1H-imidazol-2-yl]-5-oxo-1,2,3,6,7,8,9,9a-octahydropyrrolo[1,2-a]azepin-6-yl]carbamate
   Show/Hide
C42H50N8O8
 2
1
EC50 = 0.047 nM
   TI
   LI
   LO
   TS
2
EC50 = 0.707 nM
   TI
   LI
   LO
   TS
CP0868534
methyl N-[(3S,6R,9aR)-3-[5-[4-[4-[2-[(2S)-1-[(2S)-2-(methoxycarbonylamino)-3-methyl-butanoyl]pyrrolidin-2-yl]-1H-imidazol-5-yl]phenyl]phenyl]-1H-imidazol-2-yl]-5-oxo-1,2,3,6,7,8,9,9a-octahydropyrrolo[1,2-a]azepin-6-yl]carbamate
   Show/Hide
C40H48N8O6
 2
1
EC50 = 0.059 nM
   TI
   LI
   LO
   TS
2
EC50 = 0.673 nM
   TI
   LI
   LO
   TS
CP0911877
methyl N-[(3S,6S,9aR)-3-[5-[4-[4-[2-[(8S)-7-[(2S)-2-(methoxycarbonylamino)-3-methyl-butanoyl]-1,4-dioxa-7-azaspiro[4.4]nonan-8-yl]-1H-imidazol-5-yl]phenyl]phenyl]-1H-imidazol-2-yl]-5-oxo-1,2,3,6,7,8,9,9a-octahydropyrrolo[1,2-a]azepin-6-yl]carbamate
   Show/Hide
C42H50N8O8
 2
1
EC50 = 0.064 nM
   TI
   LI
   LO
   TS
2
EC50 = 1.524 nM
   TI
   LI
   LO
   TS
CP0951256
methyl N-[(3S,6R,9aS)-3-[5-[4-[4-[2-[(8S)-7-[(2S)-2-(methoxycarbonylamino)-3-methyl-butanoyl]-1,4-dioxa-7-azaspiro[4.4]nonan-8-yl]-1H-imidazol-5-yl]phenyl]phenyl]-1H-imidazol-2-yl]-5-oxo-1,2,3,6,7,8,9,9a-octahydropyrrolo[1,2-a]azepin-6-yl]carbamate
   Show/Hide
C42H50N8O8
 2
1
EC50 = 0.08 nM
   TI
   LI
   LO
   TS
2
EC50 = 14.52 nM
   TI
   LI
   LO
   TS
CP0951258
methyl N-[(1S)-1-[(8S)-8-[5-[4-[4-[2-[(3S,6S,9aR)-6-(dimethylamino)-5-oxo-1,2,3,6,7,8,9,9a-octahydropyrrolo[1,2-a]azepin-3-yl]-1H-imidazol-5-yl]phenyl]phenyl]-1H-imidazol-2-yl]-1,4-dioxa-7-azaspiro[4.4]nonane-7-carbonyl]-2-methyl-propyl]carbamate
   Show/Hide
C42H52N8O6
 2
1
EC50 = 0.084 nM
   TI
   LI
   LO
   TS
2
EC50 = 7.707 nM
   TI
   LI
   LO
   TS
CP0868724
US9427428, 14::US9433609, 14
   Show/Hide
C48H46N8O6
 1
1
EC50 = 0.093 nM
   TI
   LI
   LO
   TS
CP0868533
methyl N-[(3S,6S,9aS)-3-[5-[4-[4-[2-[(2S)-1-[(2S)-2-(methoxycarbonylamino)-3-methyl-butanoyl]pyrrolidin-2-yl]-1H-imidazol-5-yl]phenyl]phenyl]-1H-imidazol-2-yl]-5-oxo-1,2,3,6,7,8,9,9a-octahydropyrrolo[1,2-a]azepin-6-yl]carbamate
   Show/Hide
C40H48N8O6
 2
1
EC50 = 0.109 nM
   TI
   LI
   LO
   TS
2
EC50 = 17.44 nM
   TI
   LI
   LO
   TS
CP0967154
methyl N-[(3S,6R,9aS)-3-[5-[4-[4-[2-[(2S)-1-[(2S)-2-(methoxycarbonylamino)-3-methyl-butanoyl]pyrrolidin-2-yl]-1H-imidazol-5-yl]phenyl]phenyl]-1H-imidazol-2-yl]-5-oxo-1,2,3,6,7,8,9,9a-octahydropyrrolo[1,2-a]azepin-6-yl]carbamate
   Show/Hide
C40H48N8O6
 2
1
EC50 = 0.133 nM
   TI
   LI
   LO
   TS
2
EC50 = 12.48 nM
   TI
   LI
   LO
   TS
CP0943048
methyl N-[(1S)-1-[(8S)-8-[5-[4-[4-[2-[(3S,6S,9aS)-6-(dimethylamino)-5-oxo-1,2,3,6,7,8,9,9a-octahydropyrrolo[1,2-a]azepin-3-yl]-1H-imidazol-5-yl]phenyl]phenyl]-1H-imidazol-2-yl]-1,4-dioxa-7-azaspiro[4.4]nonane-7-carbonyl]-2-methyl-propyl]carbamate
   Show/Hide
C42H52N8O6
 2
1
EC50 = 0.209 nM
   TI
   LI
   LO
   TS
2
EC50 = 32.16 nM
   TI
   LI
   LO
   TS
CP0953793
methyl N-[(1S)-1-[(8S)-8-[5-[4-[4-[2-[(3S,6R,9aS)-6-(dimethylamino)-5-oxo-1,2,3,6,7,8,9,9a-octahydropyrrolo[1,2-a]azepin-3-yl]-1H-imidazol-5-yl]phenyl]phenyl]-1H-imidazol-2-yl]-1,4-dioxa-7-azaspiro[4.4]nonane-7-carbonyl]-2-methyl-propyl]carbamate
   Show/Hide
C42H52N8O6
 2
1
EC50 = 0.217 nM
   TI
   LI
   LO
   TS
2
EC50 = 119.15 nM
   TI
   LI
   LO
   TS
CP0903192
US9427428, 12::US9433609, 12
   Show/Hide
C46H54N8O8
 1
1
EC50 = 0.275 nM
   TI
   LI
   LO
   TS
CP0953457
methyl N-[(1S)-1-[(8S)-8-[5-[4-[4-[2-[(3S,6R,9aR)-6-(dimethylamino)-5-oxo-1,2,3,6,7,8,9,9a-octahydropyrrolo[1,2-a]azepin-3-yl]-1H-imidazol-5-yl]phenyl]phenyl]-1H-imidazol-2-yl]-1,4-dioxa-7-azaspiro[4.4]nonane-7-carbonyl]-2-methyl-propyl]carbamate
   Show/Hide
C42H52N8O6
 2
1
EC50 = 0.298 nM
   TI
   LI
   LO
   TS
2
EC50 = 10.63 nM
   TI
   LI
   LO
   TS
CP0923330
US9427428, 6::US9433609, 6
   Show/Hide
C40H46N8O8
 1
1
EC50 = 1.013 nM
   TI
   LI
   LO
   TS
CP0969801
US9427428, 6::US9433609, 6
   Show/Hide
C40H46N8O8
 1
1
EC50 = 1.013 nM
   TI
   LI
   LO
   TS
CP0960189
US9427428, 10
   Show/Hide
C42H50N8O8
 1
1
EC50 = 1.032 nM
   TI
   LI
   LO
   TS
CP0909845
US9427428, 15
   Show/Hide
C46H54N8O6
 1
1
EC50 = 1.192 nM
   TI
   LI
   LO
   TS
CP0959532
US9427428, 7::US9433609, 7
   Show/Hide
C44H54N8O6
 1
1
EC50 = 3.411 nM
   TI
   LI
   LO
   TS
CP0926760
US9427428, 19
   Show/Hide
C44H54N8O6
 1
1
EC50 = 5.186 nM
   TI
   LI
   LO
   TS
CP0957624
US9433609, 19
   Show/Hide
C44H54N8O6
 1
1
EC50 = 5.186 nM
   TI
   LI
   LO
   TS
CP0923329
US9427428, 5::US9433609, 5
   Show/Hide
C42H46N8O6
 1
1
EC50 = 10.85 nM
   TI
   LI
   LO
   TS
CP0969930
US9433609, 21
   Show/Hide
C43H52N8O7
 1
1
EC50 = 275 nM
   TI
   LI
   LO
   TS
CP0865738
US9427428, 20
   Show/Hide
C43H52N8O7
 1
1
EC50 = 336 nM
   TI
   LI
   LO
   TS
CP0913788
US9433609, 20
   Show/Hide
C43H52N8O7
 1
1
EC50 = 336 nM
   TI
   LI
   LO
   TS
Biochemical Assays
Compound ID Compound Name Compound Formula
CP0029881
ABT-267
   Show/Hide
C50H67N7O8
 3
1 EC50 = 0.014 nM
2 EC50 = 0.055 nM
3 EC50 = 0.186 nM
CP0032498
CVD-0019437
   Show/Hide
C40H50N8O6
 5
1 EC50 = 0.05 nM
2 EC50 = 0.071 nM
3 EC50 = 0.146 nM
4 EC50 = 61 nM
5 EC50 = 1260 nM
CP0701915
Daclatasvir
   Show/Hide
C40H51N9O6
 1
1 EC50 = 0.146 nM